Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $724,478 | 301 | 83.7% |
| Travel and Lodging | $73,356 | 281 | 8.5% |
| Consulting Fee | $35,510 | 18 | 4.1% |
| Food and Beverage | $30,267 | 438 | 3.5% |
| Honoraria | $1,500 | 1 | 0.2% |
| Education | $49.98 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $421,199 | 364 | $0 (2022) |
| Janssen Products, LP | $157,035 | 162 | $0 (2019) |
| Gilead Sciences, Inc. | $148,329 | 229 | $0 (2023) |
| Merck Sharp & Dohme LLC | $127,152 | 200 | $0 (2022) |
| Theratechnologies Inc. | $5,335 | 12 | $0 (2022) |
| Celgene Corporation | $2,161 | 4 | $0 (2017) |
| Janssen Biotech, Inc. | $1,540 | 49 | $0 (2022) |
| GlaxoSmithKline, LLC. | $975.41 | 9 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $300.00 | 1 | $0 (2021) |
| AbbVie, Inc. | $285.79 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $84.15 | 1 | Gilead Sciences, Inc. ($84.15) |
| 2022 | $146,496 | 146 | ViiV Healthcare Company ($117,206) |
| 2021 | $132,427 | 139 | ViiV Healthcare Company ($108,130) |
| 2020 | $104,755 | 113 | ViiV Healthcare Company ($76,625) |
| 2019 | $246,508 | 304 | ViiV Healthcare Company ($107,015) |
| 2018 | $97,839 | 137 | Janssen Products, LP ($49,250) |
| 2017 | $137,051 | 201 | Janssen Products, LP ($56,007) |
All Payment Transactions
1,041 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $84.15 | General |
| Category: HIV | ||||||
| 11/14/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 11/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $226.58 | General |
| Category: HIV | ||||||
| 11/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $113.11 | General |
| Category: HIV | ||||||
| 11/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | Cash or cash equivalent | $63.51 | General |
| Category: HIV | ||||||
| 10/22/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.32 | General |
| 10/21/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 10/21/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 10/21/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.12 | General |
| 10/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: HIV | ||||||
| 10/07/2022 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,730.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/05/2022 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/30/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $596.27 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $442.01 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $253.80 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $114.92 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $71.19 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $65.00 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $45.00 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $10.00 | General |
| Category: HIV | ||||||
| 09/21/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 29 | 85 | $24,403 | $6,897 |
| 2021 | 2 | 31 | 125 | $34,738 | $10,314 |
| 2020 | 2 | 39 | 126 | $22,032 | $6,205 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 85 | $24,403 | $6,897 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 103 | $30,488 | $9,299 | 30.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 22 | $4,250 | $1,015 | 23.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 25 | 92 | $14,076 | $3,609 | 25.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 14 | 34 | $7,956 | $2,596 | 32.6% |
About Dr. Timothy Kanter, M.D
Dr. Timothy Kanter, M.D is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083706535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Kanter, M.D has received a total of $865,160 in payments from pharmaceutical and medical device companies, with $84.15 received in 2023. These payments were reported across 1,041 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($724,478).
As a Medicare-enrolled provider, Kanter has provided services to 99 Medicare beneficiaries, totaling 336 services with total Medicare billing of $23,415. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bronx, NY
- Active Since 09/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083706535
Products in Payments
- DOVATO (Drug) $291,599
- Biktarvy (Drug) $81,672
- CABENUVA (Biological) $72,241
- Symtuza (Drug) $55,528
- PREZCOBIX (Drug) $55,516
- ISENTRESS (Drug) $47,179
- DELSTRIGO (Drug) $41,991
- APRETUDE (Biological) $33,605
- PIFELTRO (Drug) $20,070
- ZEPATIER (Drug) $15,201
- TIVICAY (Drug) $12,351
- Genvoya (Drug) $8,510
- TROGARZO (Drug) $3,188
- Otezla (Drug) $2,161
- Descovy (Drug) $1,890
- SYMTUZA (Drug) $729.12
- RUKOBIA (Drug) $352.60
- SOLIQUA 100/33 (Biological) $300.00
- Mytesi (Drug) $241.61
- Humira (Biological) $148.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Bulent Atac, Md, MD
Internal Medicine — Payments: $654,500
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229
Amit Verma, Md, MD
Internal Medicine — Payments: $128,888